| 1 |
Wu Z, Zeng J, Wu M, Liang Q, Li B, Hou G, Lin Z, Xu W. Identification and validation of the pyroptosis-related long noncoding rna signature to predict the prognosis of patients with bladder cancer. Medicine (Baltimore) 2023;102:e33075. [PMID: 36827075 DOI: 10.1097/MD.0000000000033075] [Reference Citation Analysis]
|
| 2 |
Li M, Nurzat Y, Huang H, Min P, Zhang X. Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB. Front Genet 2023;14:1028044. [PMID: 36816017 DOI: 10.3389/fgene.2023.1028044] [Reference Citation Analysis]
|
| 3 |
Xiong X, Chen C, Yang J, Ma L, Wang X, Zhang W, Yuan Y, Peng M, Li L, Luo P. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1024956] [Reference Citation Analysis]
|
| 4 |
Tang D, Li Y, Tang Y, Zheng H, Luo W, Li Y, Li Y, Wang Z, Wu S. Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model. Front Genet 2022;13:918705. [DOI: 10.3389/fgene.2022.918705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Wu Y, Zhang L, He S, Guan B, He A, Yang K, Gong Y, Li X, Zhou L. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer. Aging (Albany NY) 2020;12:23306-25. [PMID: 33221763 DOI: 10.18632/aging.104115] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 6 |
Lai J, Chen B, Zhang G, Li X, Mok H, Liao N. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature. J Transl Med 2020;18:416. [PMID: 33160384 DOI: 10.1186/s12967-020-02578-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 7 |
Bi H, Shang Z, Jia C, Wu J, Cui B, Wang Q, Ou T. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis. Onco Targets Ther 2020;13:11277-88. [PMID: 33177836 DOI: 10.2147/OTT.S266067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Miao YD, Wang JT, Yang Y, Ma XP, Mi DH. Identification of prognosis-associated immune genes and exploration of immune cell infiltration in colorectal cancer.Biomark Med. 2020;14:1353-1369. [PMID: 33064017 DOI: 10.2217/bmm-2020-0024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Wang C, Yang Y, Yin L, Wei N, Hong T, Sun Z, Yao J, Li Z, Liu T. Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis. Front Oncol 2020;10:931. [PMID: 32695668 DOI: 10.3389/fonc.2020.00931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 10 |
Wang Y, Du L, Yang X, Li J, Li P, Zhao Y, Duan W, Chen Y, Wang Y, Mao H, Wang C. A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer. Aging (Albany NY) 2020;12:2857-79. [PMID: 32047140 DOI: 10.18632/aging.102782] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 11 |
Qiu H, Hu X, He C, Yu B, Li Y, Li J. Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes. Front Genet 2020;11:12. [PMID: 32117435 DOI: 10.3389/fgene.2020.00012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 16.7] [Reference Citation Analysis]
|
